関連する実験動画
Updated: Sep 9, 2025
06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
8.8K
779人の転移性前立腺がん患者の生殖線病原性変異の流行
Michiel Vlaming1, Wouter Koole1, R Jeroen A van Moorselaar2
1Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
BJU international
|September 2, 2025
まとめ
CHEK2,ATM,BRCA2遺伝子の生殖線病原性変異 (gPVs) は,転移性前立腺がん (mPCa) のオランダ人男性においてより一般的です. 家族歴のような特定の要因は,これらの癌に関連した変異を運ぶ可能性を高めます.
科学分野:
- 腫瘍学
- 遺伝学
- 癌 研究
背景:
- 転移性前立腺がん (mPCa) は遺伝的傾向と関連している.
- mPCa患者のリスク評価と治療戦略において,DNA損傷修復遺伝子における生殖線病原性変異 (gPVs) の有病率を理解することは極めて重要です.
研究 の 目的:
- オランダのmPCa患者における乳がん関連遺伝子のgPVの頻度を決定する.
- この集団でgPVを携わっている特定の危険因子を特定する.
主な方法:
- 15のセンターを対象とした将来的な多センターコホート研究
- BRCA1,BRCA2,ATM,CHEK2,PALB2の生殖系統遺伝子検査は,mPCa (n=779) の患者に提供されました.
- 流行率は参照集団 (n=16,823) と比較され,gPVの確率に影響する要因が特定されました.
主要な成果:
- mPCa患者の5. 9%がDNA損傷修復遺伝子のgPVを携えていた.
- CHEK2,ATM,BRCA2におけるgPVは,参照集団と比較してmPCa患者において有意に多く見られた.
- 二次原発がん,早期発症の乳がんや臓がんの家族歴,またはユダヤ人の祖先を持つ患者では,gPVの可能性が高かった.
結論:
- CHEK2,ATM,BRCA2の生殖線病原性変異は,男性の転移性前立腺がんと関連しています.
- 医療従事者は,特定の危険因子を持つmPCa患者に対する生殖遺伝検査を検討すべきである.
- gPVを特定することで,個別化されたリスク管理と治療方法の情報を得ることができます.
関連する概念動画
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K